---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/273828880.md"
description: "With only six months left until July 1, 2026, the implementation of Article 75 of the National Medical Products Administration's \"Special Regulations on the Registration of Traditional Chinese Medicine\" is entering its final window period. This regulation, referred to in the industry as the \"death clause\" for proprietary Chinese medicines, clearly states that after three years of implementation starting from July 1, 2023, the contraindications in the instructions will be prohibited"
datetime: "2026-01-27T10:41:14.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/273828880.md)
  - [en](https://longbridge.com/en/news/273828880.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/273828880.md)
---

# 

Adverse Reactions

### Related Stocks

- [512290.CN](https://longbridge.com/en/quote/512290.CN.md)
- [159929.CN](https://longbridge.com/en/quote/159929.CN.md)
- [600436.CN](https://longbridge.com/en/quote/600436.CN.md)
- [000999.CN](https://longbridge.com/en/quote/000999.CN.md)
- [159849.CN](https://longbridge.com/en/quote/159849.CN.md)
- [516500.CN](https://longbridge.com/en/quote/516500.CN.md)
- [00570.HK](https://longbridge.com/en/quote/00570.HK.md)
- [510660.CN](https://longbridge.com/en/quote/510660.CN.md)
- [588130.CN](https://longbridge.com/en/quote/588130.CN.md)
- [600129.CN](https://longbridge.com/en/quote/600129.CN.md)
- [600535.CN](https://longbridge.com/en/quote/600535.CN.md)
- [588250.CN](https://longbridge.com/en/quote/588250.CN.md)
- [520880.CN](https://longbridge.com/en/quote/520880.CN.md)
- [600085.CN](https://longbridge.com/en/quote/600085.CN.md)
- [159837.CN](https://longbridge.com/en/quote/159837.CN.md)
- [600329.CN](https://longbridge.com/en/quote/600329.CN.md)
- [513200.CN](https://longbridge.com/en/quote/513200.CN.md)
- [00874.HK](https://longbridge.com/en/quote/00874.HK.md)
- [159506.CN](https://longbridge.com/en/quote/159506.CN.md)
- [002603.CN](https://longbridge.com/en/quote/002603.CN.md)
- [520690.CN](https://longbridge.com/en/quote/520690.CN.md)
- [159102.CN](https://longbridge.com/en/quote/159102.CN.md)
- [000538.CN](https://longbridge.com/en/quote/000538.CN.md)
- [600566.CN](https://longbridge.com/en/quote/600566.CN.md)
- [159859.CN](https://longbridge.com/en/quote/159859.CN.md)
- [560600.CN](https://longbridge.com/en/quote/560600.CN.md)
- [01666.HK](https://longbridge.com/en/quote/01666.HK.md)
- [03613.HK](https://longbridge.com/en/quote/03613.HK.md)
- [600332.CN](https://longbridge.com/en/quote/600332.CN.md)
- [516820.CN](https://longbridge.com/en/quote/516820.CN.md)
- [589720.CN](https://longbridge.com/en/quote/589720.CN.md)
- [159892.CN](https://longbridge.com/en/quote/159892.CN.md)
- [159615.CN](https://longbridge.com/en/quote/159615.CN.md)
- [512010.CN](https://longbridge.com/en/quote/512010.CN.md)

## Related News & Research

- [Hunan High-Tech Industry Investment chair Li Aidong visits Tianjin Pharma for operations review](https://longbridge.com/en/news/295429562.md)
- [Tianjin Pharmaceutical Da Ren Tang enters annual distribution deal with Taiping Medicine, Zhongxin Medicine](https://longbridge.com/en/news/295236477.md)
- [Guangzhou Baiyunshan Pharmaceutical schedules extraordinary general meeting](https://longbridge.com/en/news/295202412.md)
- [China TCM expects H1 loss of RMB 800 million-RMB 850 million](https://longbridge.com/en/news/293043444.md)